Directory

>

Friedrich Graf Finckenstein

avatar

Friedrich Graf Finckenstein

Chief Medical Officer | Iovance Biotherapeutics, Inc.

San Carlos, California, United States

View contact details (it's free)

Friedrich Graf Finckenstein

Summary

Friedrich Graf Finckenstein is a seasoned Chief Medical Officer with over 13 years of experience in drug development and clinical research, particularly in oncology. He has a robust background in clinical medicine, with 8 years dedicated to pediatric hematology and oncology, and has led significant research initiatives in molecular biology and cell biology. His leadership at Iovance Biotherapeutics showcases his commitment to advancing autologous cell therapies for cancer treatment. Friedrich's previous roles at Roche and Bristol Myers Squibb highlight his expertise in managing large teams and overseeing complex clinical trials from discovery to regulatory submission. He is recognized for his strategic contributions to oncology portfolio management and has a proven track record in translational medicine. With a medical degree from the University of Hamburg, he combines clinical insight with a strong research foundation, making him a valuable asset in the biopharmaceutical industry. Friedrich's passion for innovation in cancer therapies drives his professional journey, emphasizing his dedication to improving patient outcomes through advanced medical solutions.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Friedrich Graf Finckenstein

Work Experience

company logo

Chief Medical Officer at

Iovance Biotherapeutics, Inc.

July 2019 - Present

company logo

Global Head of Oncology Translational Medicine, Pharma Research and Early Development (pRED) at

ROCHE LEON HOLDINGS

November 2015 - June 2019

company logo

Medical Group Director at

Bristol Myers Squibb

January 2006 - January 2015

💼

Visiting Research Scholar at

Children's Hospital Los Angeles Medical Group, Inc.

January 2003 - January 2006

company logo

Clinical Staff Member, Department of Pediatric Hematology / Oncology at

Universitätsklinikum Hamburg Eppendorf

January 1997 - January 2003

💼

Post-Doc at

Licr San Diego

January 1994 - January 1997

Logos provided by Logo.dev

Friedrich Graf Finckenstein

Education

University of Hamburg, Dr.Med. (Medical Doctor)

January 1984 - January 1992

Frequently Asked Questions about Friedrich Graf Finckenstein

What is Friedrich Graf Finckenstein email address?

Friedrich Graf Finckenstein's primary email address is **********************@iovance.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Friedrich Graf Finckenstein work for?

Friedrich Graf Finckenstein is a Chief Medical Officer at Iovance Biotherapeutics, Inc., a company specializing in Commercial physical research.

Where Friedrich Graf Finckenstein graduated from?

Friedrich Graf Finckenstein holds a degree in Medicine from University of Hamburg.

How can I directly contact Friedrich Graf Finckenstein?

To contact Friedrich Graf Finckenstein directly, you can use the email address **********************@iovance.com. Complete contact information is available upon registration with Muraena.

Is Friedrich Graf Finckenstein an immigrant?

Yes, Friedrich Graf Finckenstein is an immigrant and currently based in United States

Who is Friedrich Graf Finckenstein?

Friedrich Graf Finckenstein is a seasoned Chief Medical Officer with over 13 years of experience in drug development and clinical research, particularly in oncology. He has a robust background in clinical medicine, with 8 years dedicated to pediatric hematology and oncology, and has led significant research initiatives in molecular biology and cell biology. His leadership at Iovance Biotherapeutics showcases his commitment to advancing autologous cell therapies for cancer treatment. Friedrich's previous roles at Roche and Bristol Myers Squibb highlight his expertise in managing large teams and overseeing complex clinical trials from discovery to regulatory submission. He is recognized for his strategic contributions to oncology portfolio management and has a proven track record in translational medicine. With a medical degree from the University of Hamburg, he combines clinical insight with a strong research foundation, making him a valuable asset in the biopharmaceutical industry. Friedrich's passion for innovation in cancer therapies drives his professional journey, emphasizing his dedication to improving patient outcomes through advanced medical solutions.

Friedrich`s contact details

mail

**********************@iovance.com

**********************@bms.com

Colleagues

avatar
Selda Samakoglu Md

Executive Director, Clinical Development, Oncology

avatar
Stephen Camiolo

Vice President, Cell Therapy Account Teams

avatar
Peter Prieto Md Mph Cmq Facs Fsso

Senior Vice President, Medical Affairs

avatar
Ahmed Tawashi

Vice President, Research Alliances

avatar
Fred Vogt

Interim CEO and General Counsel

Gary Chen

Executive Director

Brian Shew

SVP Head of Digital and Information Technology

Pharm Guy Ruble Rac-Drugs

Vice President, Regulatory Affairs

avatar
Ryan Yamagata

Executive Director, CMC Biostatistics

Tim Logan

VP, Global Commercial Operations

View Contact details (it's free)
Request Profile Removal